Besunyen Holdings Company Limited
HKSE 0926.HK
Besunyen Holdings Company Limited Revenue Per Share for the year ending December 31, 2023: USD 0.33
-
Besunyen Holdings Company Limited Revenue Per Share for the year ending December 31, 2022 was USD 2.43, a -17.19% change year over year.
-
Besunyen Holdings Company Limited Revenue Per Share for the year ending December 31, 2021 was USD 2.94, a -12.52% change year over year.
-
Besunyen Holdings Company Limited Revenue Per Share for the year ending December 31, 2020 was USD 3.36, a 69.79% change year over year.
-
Besunyen Holdings Company Limited Revenue Per Share for the year ending December 31, 2019 was USD 1.98, a 111.96% change year over year.
| Date | Revenue Per Share | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) |
|---|
| CEO | Mr. Yihong Zhao |
| IPO Date | Sept. 29, 2010 |
| Location | China |
| Headquarters | Asia Financial Center |
| Employees | 151 |
| Sector | Health Care |
| Industries | |
Besunyen Holdings Company Limited engages in the research and development, production, and sale of therapeutic tea products and pharmaceuticals in the People's Republic of China. It offers its therapeutic tea products under the Besunyen brand; herbal tea; and Besunyen Detox and Besunyen slimming tea. The company also provides functional teas, such as Besunyen Fit Tea; and LARLLY Orlistat weight-loss medicine, as well as develops, produces, and sells over-the-counter (OTC) medicines comprising Besunyen Orlistat weight-loss capsule. It sells its products through OTC pharmacies and the retail terminals in shopping malls and supermarkets; and distributors and sub-distributors, as well as through e-commerce platforms. The company was founded in 2000 and is based in Beijing, the People's Republic of China. Besunyen Holdings Company Limited is a subsidiary of Foreshore Holding Group Limited.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email